Internal Medicine, Hematology & Oncology · Providence, RI
NPI
1790797538
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
593 Eddy St, Apc 138
Providence, RI, 02903
Phone (401) 444-5391
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,093 services
Medicare patients, 2024
459
Average age 76
Drug cost, 2024
$8.0M
1,456 prescriptions
Company payments, 2023
$21.31
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James N Butera was code 99213 (office e&m - established), 417 times for 245 patients. In total James N Butera billed 1,093 services in 15 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Facility | 417 | 245 | $49.00 | $20K |
| 99214 Office E&M - Established | Facility | 287 | 102 | $72.04 | $21K |
| 99213 Office E&M - Established | Office | 164 | 89 | $46.74 | $7,666 |
| 99204 Office E&M - New | Facility | 58 | 58 | $100.68 | $5,840 |
| 99442 Telephone Services | Office | 41 | 36 | $62.78 | $2,574 |
| 99214 Office E&M - Established | Office | 36 | 27 | $76.73 | $2,762 |
| 99203 Office E&M - New | Facility | 12 | 12 | $64.60 | $775 |
| 99222 Hospital E&M - Initial | Facility | 11 | 11 | $102.66 | $1,129 |
By year: 2022 $54K for 935 services; 2023 $61K for 1,034 services; 2024 $67K for 1,093 services.
Medicare prescription drug claims, 2024
In 2024, the drug James N Butera prescribed most often to Medicare patients was Hydroxyurea, with 177 prescriptions and refills. In total James N Butera wrote 1,456 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 177 | 413 | 45 | $5,733 |
| Eliquis Apixaban | 142 | 186 | 30 | $102K |
| Lenalidomide Generic | 110 | 110 | 16 | $1.3M |
| Revlimid Lenalidomide | 84 | 84 | 14 | $1.4M |
| Imatinib Mesylate Generic | 82 | 82 | Under 11 | $32K |
| Pomalyst Pomalidomide | 76 | 76 | 11 | $1.5M |
| Valacyclovir Valacyclovir Hcl | 63 | 118 | 22 | $2,099 |
| Prednisone Generic | 52 | 71 | 16 | $403 |
| Calquence Acalabrutinib Maleate | 49 | 49 | Under 11 | $678K |
| Brukinsa Zanubrutinib | 47 | 47 | Under 11 | $652K |
| Xarelto Rivaroxaban | 47 | 67 | Under 11 | $36K |
| Dexamethasone Generic | 43 | 51 | 16 | $544 |
| Jakafi Ruxolitinib Phosphate | 38 | 38 | Under 11 | $636K |
| Venclexta Venetoclax | 37 | 37 | Under 11 | $357K |
| Ondansetron Hcl Generic | 29 | 29 | 13 | $344 |
Brand drugs: 629 claims; generic drugs: 827 claims; opioid claims: 17.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid James N Butera $21.31 ($21.31 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $21.31.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $21.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.